eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 01/02/2012
PIL Flolan Injection 1.5mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 05/07/2011 and displayed until 01/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 31/10/2006 and displayed until 05/07/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 13/04/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 18/02/2005 and displayed until 13/04/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about the device
  • Company name change or merger
Updated on 23/09/2002 and displayed until 18/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 08/05/2002 and displayed until 23/09/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 22/03/2001 and displayed until 08/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   epoprostenol sodium